E2F1 and cancer: In the neuroblastoma cell line, the E2F-targeted portions of cancer pathways, thermogenesis, mTOR signaling, insulin signaling, and circadian entrainment were all inhibited (Fig. 5B), as one would expect based on the previous research on E2F1.